Cargando…
ADAM10 Gene Variants in AD Patients and Their Relationship to CSF Protein Levels
ADAM10 is the main α-secretase acting in the non-amyloidogenic processing of APP. We hypothesized that certain rare ADAM10 variants could increase the risk for AD by conferring the age-related downregulation of α-secretase. The ADAM10 gene was sequenced in 103 AD cases (82% familial) and 96 cognitiv...
Autores principales: | Agüero-Rabes, Pablo, Pérez-Pérez, Julián, Cremades-Jimeno, Lucía, García-Ayllón, María-Salud, Gea-González, Adriana, Sainz, María José, Mahillo-Fernández, Ignacio, Téllez, Raquel, Cárdaba, Blanca, Sáez-Valero, Javier, Gómez-Tortosa, Estrella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093927/ https://www.ncbi.nlm.nih.gov/pubmed/37047093 http://dx.doi.org/10.3390/ijms24076113 |
Ejemplares similares
-
α-Secretase nonsense mutation (ADAM10 Tyr167*) in familial Alzheimer’s disease
por: Agüero, Pablo, et al.
Publicado: (2020) -
Levels of ADAM10 are reduced in Alzheimer’s disease CSF
por: Sogorb-Esteve, Aitana, et al.
Publicado: (2018) -
Prioritizing Molecular Biomarkers in Asthma and Respiratory Allergy Using Systems Biology
por: Cremades-Jimeno, Lucía, et al.
Publicado: (2021) -
Transmembrane Amyloid-Related Proteins in CSF as Potential Biomarkers for Alzheimer’s Disease
por: Lopez-Font, Inmaculada, et al.
Publicado: (2015) -
Peptide Allergen Immunotherapy: A New Perspective in Olive-Pollen Allergy
por: Calzada, David, et al.
Publicado: (2021)